Martens, A., & Hassel, J. C. (2018). Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab. Clinical cancer research, 22(12), . https://doi.org/10.1158/1078-0432.CCR-15-2412
Chicago Style (17th ed.) CitationMartens, Alexander, and Jessica C. Hassel. "Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab." Clinical Cancer Research 22, no. 12 (2018). https://doi.org/10.1158/1078-0432.CCR-15-2412.
MLA (9th ed.) CitationMartens, Alexander, and Jessica C. Hassel. "Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab." Clinical Cancer Research, vol. 22, no. 12, 2018, https://doi.org/10.1158/1078-0432.CCR-15-2412.